» Articles » PMID: 29464424

Prevalence and Risk Factors for CTX-M Gram-negative Bacteria in Hospitalized Patients at a Tertiary Care Hospital in Kilimanjaro, Tanzania

Overview
Publisher Springer
Date 2018 Feb 22
PMID 29464424
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Emergence and spread of extended spectrum beta-lactamase (ESBL)-producing gram-negative bacteria, mainly due to CTX-M, is a major global public health problem. Patients infected with ESBL-producing gram-negative bacteria have an increased risk of treatment failure and death. We investigated the prevalence and risk factors for CTX-M gram-negative bacteria isolated from clinical specimens of patients hospitalized at a tertiary care hospital in Kilimanjaro, Tanzania. Isolated gram-negative bacteria from inpatients admitted at Kilimanjaro Christian Medical Centre (KCMC) between August 2013 and August 2015 were fully genome sequenced. The prevalence of ESBL-producing gram-negative bacteria was determined based on the presence of bla. The odds ratio (OR) and risk factors for ESBL-producing gram-negative bacteria due to CTX-M were assessed using logistic regression models. The overall CTX-M prevalence (95% CI) was 13.6% (10.1-18.1). Adjusted for other factors, the OR of CTX-M gram-negative bacteria for patients previously hospitalized was 0.26 (0.08-0.88), p = 0.031; the OR for patients currently on antibiotics was 4.02 (1.29-12.58), p = 0.017; the OR for patients currently on ceftriaxone was 0.14 (0.04-0.46), p = 0.001; and the OR for patients with wound infections was 0.24 (0.09-0.61), p = 0.003. The prevalence of ESBL-producing gram-negative bacteria due to CTX-M in this setting is relatively low compared to other previous reports in similar settings. However, to properly stop further spread in the hospital, we recommend setting up a hospital surveillance system that takes full advantage of the available next-generation sequencing facility to routinely screen for all types of bacterial resistance genes.

Citing Articles

Frequency of Fecal Carriage of ESBL Resistance Genes in Multidrug-Resistant Isolates from Cancer Patients at Laquintinie Hospital, Douala, Littoral Region, Cameroon.

Kengne M, Mbaveng A, Karimo O, Dadjo B, Tsobeng O, Marbou W Int J Microbiol. 2024; 2024:7685878.

PMID: 38962396 PMC: 11222006. DOI: 10.1155/2024/7685878.


Antibiotic use at a tertiary hospital in Tanzania: findings from a point prevalence survey.

Katyali D, Kawau G, Blomberg B, Manyahi J Antimicrob Resist Infect Control. 2023; 12(1):112.

PMID: 37817204 PMC: 10566109. DOI: 10.1186/s13756-023-01317-w.


Molecular Epidemiological Surveillance of CTX-M-15-producing Klebsiella pneumoniae from the patients of a teaching hospital in Sindh, Pakistan.

Muzaheed , Sattar Shaikh N, Shaikh S, Acharya S, Moosa S, Shaikh M F1000Res. 2021; 10:444.

PMID: 34909182 PMC: 8596178. DOI: 10.12688/f1000research.53221.3.


Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.

Letara N, Ngocho J, Karami N, Msuya S, Nyombi B, Kassam N Sci Rep. 2021; 11(1):22759.

PMID: 34815472 PMC: 8611091. DOI: 10.1038/s41598-021-02186-2.


Genetic Determinants of Resistance among ESBL-Producing in Community and Hospital Settings in East, Central, and Southern Africa: A Systematic Review and Meta-Analysis of Prevalence.

Onduru O, Mkakosya R, Aboud S, Rumisha S Can J Infect Dis Med Microbiol. 2021; 2021:5153237.

PMID: 34122680 PMC: 8192179. DOI: 10.1155/2021/5153237.


References
1.
Esteve-Palau E, Solande G, Sanchez F, Sorli L, Montero M, Guerri R . Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study. J Infect. 2015; 71(6):667-74. DOI: 10.1016/j.jinf.2015.08.012. View

2.
Muellner P, Pleydell E, Pirie R, Baker M, Campbell D, Carter P . Molecular-based surveillance of campylobacteriosis in New Zealand--from source attribution to genomic epidemiology. Euro Surveill. 2013; 18(3). View

3.
Maslikowska J, Walker S, Elligsen M, Mittmann N, Palmay L, Daneman N . Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect. 2015; 92(1):33-41. DOI: 10.1016/j.jhin.2015.10.001. View

4.
Bercion R, Mossoro-Kpinde D, Manirakiza A, Le Faou A . Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J Infect Dev Ctries. 2009; 3(3):187-90. DOI: 10.3855/jidc.34. View

5.
Mshana S, Hain T, Domann E, Lyamuya E, Chakraborty T, Imirzalioglu C . Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania. BMC Infect Dis. 2013; 13:466. PMC: 3851032. DOI: 10.1186/1471-2334-13-466. View